Health Canada and peptides: the notices, dated

Between June 2024 and July 2026, Health Canada published at least eight notices about peptides or peptide drugs: six public advisories, one recall and one statement on a court injunction. Read together, they point the same way: peptides are generally regulated as prescription drugs, products Health Canada has not authorized are illegal to sell, and a research-use label does not change that. This page lists each notice, newest first, with one quoted line and its link.

This is the list of notices this library has found and checked. It may not be complete. Several notices name the sellers involved; we do not name them in our words.

29 July 2026: statement on a permanent injunction

Health Canada announced a permanent injunction against a Canadian online seller of peptides.

"In Canada, injectable peptides are regulated as prescription drugs and must be authorized by Health Canada before they can be sold."

Health Canada statement, 29 Jul 2026, retrieved 4 October 2026.

Read line by line on the July 2026 injunction.

7 May 2026: recall of two peptide powders

A recall, listed by Health Canada as Type I, of two powders sold as raw ingredients.

"Products sold are unauthorized active pharmaceutical ingredients (APIs)."

Health Canada recall, 7 May 2026, retrieved 12 October 2026.

Explained on the May 2026 peptide powder recall.

9 April 2026: advisory on peptides bought online

The advisory that set out Health Canada's position on research-use labels.

"Health Canada continues to identify products marketed as “For Research Use Only – Not for Human Consumption.” This type of labelling does not make these products legal or exempt from regulatory requirements. Canadians are advised not to buy or use products labelled in this way."

Health Canada public advisory, 9 Apr 2026, retrieved 4 October 2026.

Explained on the April 2026 peptide advisory.

21 January 2026: advisory on GLP-1 products

An advisory on unauthorized GLP-1 products, a group of peptide drugs.

"Health Canada has identified various retailers in Canada selling unauthorized GLP-1 products, both in stores and online."

Health Canada public advisory, 21 Jan 2026, retrieved 12 October 2026.

Explained on GLP-1 peptides and the Canadian rules.

1 August 2025: products seized from a Canadian online seller

"Injectable peptides are regulated as prescription drugs in Canada."

Health Canada public advisory, 1 Aug 2025, retrieved 12 October 2026.

"Selling unauthorized drugs is illegal in Canada."

Health Canada public advisory, 1 Aug 2025, retrieved 12 October 2026.

14 April 2025: products sold by a Canadian online seller

"Authorized health products have an eight-digit Drug Identification Number (DIN), Natural Product Number (NPN) or Homeopathic Drug Number (DIN-HM)."

Health Canada advisory, 14 Apr 2025, retrieved 4 October 2026.

1 April 2025: products seized from a wellness centre

"Health Canada has not authorized any of the products seized"

Health Canada public advisory, 1 Apr 2025, retrieved 12 October 2026.

The three 2025 advisories are explained together on Health Canada's 2025 peptide advisories.

26 June 2024: products sold on two websites

The earliest notice on this list, updated on 19 July 2024.

"Most synthetic injectable peptides are regulated as prescription drugs in Canada and require a prescription"

Health Canada public advisory, 26 Jun 2024, retrieved 12 October 2026.

What the list shows

Three things run through these notices:

1. Peptides are generally regulated as prescription drugs. The wording moves from "Most synthetic injectable peptides" in 2024 to "peptides are generally regulated as prescription drugs" in April 2026.
2. Unauthorized means illegal to sell. The notices describe the products involved as unauthorized. The 1 August 2025 advisory, quoted above, and the July 2026 statement (see the injunction page) both say that selling unauthorized drugs is illegal.
3. Action follows. The notices move from warnings to seizures, a recall and, in 2026, a court order.

The check Health Canada points to in its April 2026 advisory is an eight-digit DIN on the label and a listing in the Drug Product Database. See DIN, NPN and how to check a product.

How this list is kept

Each morning a watch reads Health Canada's recall and news feeds for the word "peptide". A new notice opens a draft for review; it is added here only after its lines are checked against the notice. See how verification works.

New notices are added here first. Get one email when this list changes.